Diane E. Wilfong - Feb 6, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controller & CAO
Signature
/s/ Edward S. Son by Power of Attorney for Diane E. Wilfong
Stock symbol
GILD
Transactions as of
Feb 6, 2023
Transactions value $
-$48,793
Form type
4
Date filed
2/7/2023, 04:47 PM
Previous filing
Jan 26, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1.86K +6.07% 32.6K Feb 6, 2023 Direct F1
transaction GILD Common Stock Tax liability -$48.8K -565 -1.73% $86.36 32K Feb 6, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.86K -14.42% 11.1K Feb 6, 2023 Common Stock 1.86K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.